BSE filing, BSE: 542934. Summary written from the filing by ALFA Finder's alert engine.
Chandra Bhagat Pharma Ltd: key numbers
- Share price
- ₹58.00
- Market cap
- ₹43.76 Cr
- Revenue (annual)
- ₹116.3 Cr
- Net profit (annual)
- ₹3.05 Cr
- P/E (TTM)
- 14.4×Sector 42.0×
- Promoter holding
- 73.02%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chandra Bhagat Pharma Ltd
All →Chandra Bhagat Pharma Convertible Warrants
Chandra Bhagat Pharma allotted 50 lakh convertible warrants worth ₹21.90 Crore to seven promoter group members. Allotment was completed on 22 October 2026.
- Value
- ₹21.90 Cr
Chandra Bhagat Pharma Convertible Warrants
Chandra Bhagat Pharma allotted 66 lakh convertible warrants at Rs.44 each, raising Rs.7.26 Crore from 9 allottees. Warrants are convertible 1:1 into equity shares within 18 months.
- Value
- ₹7.26 Cr
Chandra Bhagat Pharma Other Announcement
Chandra Bhagat Pharma Ltd filed a certificate for non-applicability of corporate governance requirements for the September 2026 quarter. This exemption applies to SME-listed entities.
Chandra Bhagat Pharma Preferential Issue
Chandra Bhagat Pharma received BSE in-principle approval for a preferential issue of 66,00,000 warrants at Rs. 44 each. Total issue value is approximately Rs. 2.90 Crore.
- Value
- ₹2.90 Cr
Chandra Bhagat Pharma Management Change
Ms. Rajani Dawani has resigned from her position as Company Secretary and Compliance Officer of Chandra Bhagat Pharma Limited, effective September 30, 2026.
Chandra Bhagat Pharma Annual General Meeting
Chandra Bhagat Pharma Limited conducted its 23rd Annual General Meeting on September 1, 2026, covering annual accounts, director reappointment, capital increase, and warrant issuance.
Other board meeting date announcements
All →Aravali Securities & Finance Board Meeting Date
Aravali Securities will hold a board meeting on November 13, 2026 to consider unaudited half-year results. The trading window stays closed until November 15, 2026.
Filatex Fashions Board Meeting Date
Filatex Fashions schedules a November 14, 2026 board meeting to consider unaudited Q2 and half-year results. Trading window stays closed until 48 hours after results release.
Munoth Financial Services Board Meeting Date
Munoth Financial Services will hold a board meeting on 13 November 2026 to consider unaudited standalone quarterly results for September 2026. Trading window is closed from 1 October to 16 November 2026.
Mobilise App Lab Board Meeting Date
Mobilise App Lab Limited will hold a board meeting on 12-Nov-2026 to consider unaudited standalone half-yearly results for September 2026. The trading window stays closed until 14-Nov-2026.
7Seas Entertainment Board Meeting Date
7Seas Entertainment schedules a November 13, 2026 board meeting to consider unaudited standalone half-year results ended September 2026. Trading window closed October 1 to November 15.
Munoth Communication Board Meeting Date
Munoth Communication schedules a November 13, 2026 board meeting for unaudited standalone September 2026 quarter results. Trading window closed October 1 to November 16, 2026.